The most important financial indicators for the company A & B Pharm Corporation S.r.l. - Unique Identification Number 16045190:
sales in 2023 was
2.114.991
euro, registering a net profit of
65.532
euro and having an average number of
21
employees.
Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.
Sales, Profit, Employees, Debts, Capitals, Financial Results -
A & B Pharm Corporation S.r.l.
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Sales - EUR
4.467.062
3.940.020
3.413.115
2.805.477
3.224.039
3.549.733
2.857.980
2.170.065
2.046.450
2.114.991
Total Income - EUR
4.471.257
3.948.840
3.418.944
2.860.049
3.442.966
3.735.611
3.781.982
2.892.591
2.046.456
2.115.092
Total Expenses - EUR
4.431.631
3.939.828
3.972.901
3.160.614
3.430.828
4.197.939
3.763.832
2.865.829
2.045.933
2.029.291
Gross Profit/Loss - EUR
39.626
9.012
-553.958
-300.565
12.138
-462.329
18.150
26.762
523
85.800
Net Profit/Loss - EUR
29.122
3.980
-553.958
-360.388
12.138
-462.329
18.150
26.762
523
65.532
Employees
51
80
70
45
48
44
28
20
21
21
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 3.7%, from 2.046.450 euro in the year 2022, to 2.114.991 euro in 2023.
The Net Profit increased by 65.011 euro, from 523 euro in 2022, to 65.532 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
A & B Pharm Corporation S.r.l. - CUI 16045190
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
1.961.144
2.132.578
2.131.130
1.967.430
1.642.930
1.474.495
697.284
421.891
400.825
394.260
Current Assets
1.398.610
1.403.350
847.628
858.669
1.214.075
1.486.484
1.107.947
1.043.125
1.235.196
1.179.612
Inventories
829.442
973.262
324.832
378.880
405.296
528.665
487.344
223.653
282.144
272.187
Receivables
398.468
262.404
212.123
325.669
559.970
600.108
445.767
476.918
652.280
830.536
Cash
0
167.684
310.674
154.120
248.808
357.711
174.836
342.554
300.772
76.889
Shareholders Funds
797.360
916.485
416.870
49.427
60.658
265.039
278.165
417.530
419.348
371.295
Social Capital
11.155
119.738
123.456
121.366
119.139
137.905
135.291
132.290
132.701
132.298
Debts
2.552.054
2.629.554
2.583.912
2.796.328
2.817.602
2.733.842
1.564.249
1.083.845
1.253.144
1.238.937
Income in Advance
10.340
7.795
4.768
1.996
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.179.612 euro in 2023 which includes Inventories of
272.187 euro, Receivables of
830.536 euro and cash availability of
76.889 euro.
The company's Equity was valued at
371.295 euro, while total Liabilities amounted to
1.238.937 euro.
Equity decreased by -46.781 euro, from 419.348 euro in 2022, to 371.295 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - A & B Pharm Corporation S.r.l.